MedDataX Logo

Anti-HIV False Positivity Rate in Pregnant Women; and Investigating the Factors Affecting This Situation

NCT ID: NCT03777371

Last Updated: 2018-12-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

128 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-01-01

Study Completion Date

2018-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

HIV virus is an etiologic agent of ( AIDS ) immunodeficiency syndrome . It is known that the estimated rate of transfer from mother to baby is 25% to 45%, pregnancy rate is 5-10%, pregnancy rate is 15-20% and in lactation period is 5-10%. Risk factors; maternal viral load, breastfeeding, vaginal birth, and prematurity. Although there is a high rate of false positivity in prenatal screening in our country, one of the factors affecting this is the number of pregnancies.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Viral and Antiretroviral Dynamics in HIV-1 Mother-to-Child Transmission Fluids

NCT03284645

Human Immunodeficiency Virus Infection
COMPLETED

Antiretroviral Adherence Evaluation in HIV Pregnant and Postpartum Women

NCT01621347

HIV Infection Pregnancy
COMPLETED

Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission

NCT00028145

HIV Infections Pregnancy Complications, Infectious
COMPLETED

HIV Diagnosis and Treatment at Birth for Newborn With High Risk HIV Exposure

NCT03642704

Mother to Child HIV Transmission
COMPLETED PHASE4

Problems Associated With the Use of Anti-HIV Drugs in HIV-Infected Pregnant Women

NCT00017797

HIV Infections Pregnancy
COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HIV Seropositivity Acquired Immunodeficiency Syndrome Pregnancy, High Risk

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

RETROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Anti HIV Seropositive Pregnant Women

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Anti HIV seropositive Pregnant Women

Exclusion Criteria

* Anti HIV seronegative Pregnant Women
Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kanuni Sultan Suleyman Training and Research Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Pınar Yalcin bahat

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HIVinPregnancies

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Pharmacokinetics of Antiretroviral Agents in HIV-1 Infected Pregnant Women
NCT00006320 COMPLETED PHASE1
Evaluating the Pharmacokinetics, Feasibility, Acceptability, and Safety of Oral Pre-Exposure Prophylaxis for HIV Prevention During Pregnancy and Postpartum
NCT03386578 COMPLETED PHASE2
A Study to Collect Information About HIV-Positive Pregnant Women and Their Babies
NCT00000910 COMPLETED
Development of Resistance Mutations in Pregnant HIV-positive (+) Women Following Perinatal Antiretroviral Therapy in Israel
NCT00197366 TERMINATED
Immediate or Deferred Pre-exposure Prophylaxis for HIV Prevention: Safe Options for Pregnant and Lactating Women
NCT03227731 COMPLETED PHASE2/PHASE3
UNCPM 22314 - Pregnancy, Infant and Maternal Health Outcomes Study
NCT06158126 RECRUITING PHASE4
Long Term Outcomes of Therapy in Women Initiated on Lifelong ART Because of Pregnancy in DR Congo
NCT03048669 COMPLETED NA
Primary HIV Prevention in Pregnant and Lactating Ugandan Women
NCT01882998 COMPLETED NA
A Prospective, Observational Study of HIV-Infected Pregnant Women and Their Infants at Clinical Sites in Latin American and Caribbean Countries
NCT00341302 COMPLETED
Study of Perinatal Transmission of Zidovudine-Resistant HIV Among Pregnant Women Treated With Zidovudine
NCT00000828 COMPLETED
ART Readiness in HIV-infected Pregnant Women
NCT02459678 COMPLETED NA
A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)
NCT00000751 COMPLETED PHASE3
Evaluation of Barriers to Postpartum Care in HIV Infected Women
NCT01853917 COMPLETED
Pregnancy, Anti-integrase and Lymphocyte Repertoire of the Newborn
NCT04024150 COMPLETED
Supporting Oral and Long-acting PrEP Decision Making Among Pregnant Women in Lilongwe, Malawi
NCT06397690 COMPLETED NA
An Integrated Strategy to Support Antiretroviral Therapy and Pre-exposure Prophylaxis Adherence for HIV Prevention in Pregnant and Breastfeeding Women
NCT04330989 COMPLETED NA
Fetal HIV Transmission Risk and Duration of Membrane Rupture
NCT01616823 COMPLETED
Screening for TB in Pregnancy. on HIV-Infected Pregnant Women
NCT02520973 COMPLETED NA
Safety and Pharmacokinetics of Dolutegravir in Pregnant HIV Mothers and Their Neonates: A Pilot Study
NCT02245022 COMPLETED PHASE2/PHASE3
Antiretroviral Drug Levels During and After Pregnancy
NCT00616252 COMPLETED
Healthy Beginning Initiative
NCT01795261 UNKNOWN
The University of Zimbabwe College of Health Science (UZ-CHS) BIRTH COHORT Study
NCT04087239 ACTIVE_NOT_RECRUITING
Optimizing PrEP Regimens for Pregnant Women in Sub-Saharan Africa (O-PrEP Study) - Stage 1
NCT06435026 COMPLETED PHASE2
Therapeutic Drug Monitoring to oPtimize ANtiretroviral regimeNs in HIV-infected Women Who wAnt to Breastfeed
NCT05642481 COMPLETED
HIV Diagnosis in Hospitalized Malawian Infants
NCT01388452 COMPLETED NA